SCHEMBL330593

SCHEMBL330593

[O]c1c(Cl)cccc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28870275 0.80
SCHEMBL5375204 0.80
SCHEMBL3115140 0.80
SCHEMBL5370389 0.76 CYP1A2 (0.36)
SCHEMBL6656641 0.76 GABRA1 (0.46)
SCHEMBL16797132 0.74 TYK2 (0.41)
SCHEMBL16797148 0.74 CYP1A2 (0.42)
SCHEMBL5394326 0.74 CA12 (0.46)
SCHEMBL329345 0.71
SCHEMBL23239 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 316 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113429308-B Synthesis process of diclofenac sodium 安徽普利药业有限公司 2023-07-18 CN claimed
CN-114409611-A Oxadiazole hydrazide compound and preparation method and application thereof 贵州大学 2022-04-29 CN claimed
CN-113429308-A Process for synthesizing diclofenac sodium 安徽普利药业有限公司 2021-09-24 CN claimed
EP-3080090-B1 BICYCLIC HETEROARYL INDOLE ANALOGUES USEFUL AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS SA (CH) 2018-01-31 EP claimed
US-9682977-B2 Bicyclic heteroaryl indole analogues useful as ROR gamma modulators GLENMARK PHARMACEUTICALS S.A. (CH) 2017-06-20 US claimed
US-20160326163-A1 BICYCLIC HETEROARYL INDOLE ANALOGUES USEFUL AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2016-11-10 US claimed
EP-3080090-A1 BICYCLIC HETEROARYL INDOLE ANALOGUES USEFUL AS ROR GAMMA MODULATORS Glenmark Pharmaceuticals S.A. (CH) 2016-10-19 EP claimed
EP-2396316-B1 QUINAZOLINONES AS PROLYL HYDROXYLASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2015-07-01 EP claimed
WO-2015087234-A1 BICYCLIC HETEROARYL INDOLE ANALOGUES USEFUL AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2015-06-18 WO claimed
US-8937078-B2 Quinazolinones as prolyl hydroxylase inhibitors JANSSEN PHARMACEUTICA NV (BE) 2015-01-20 US claimed
US-6150360-A ADMINISTERING TO A PATIENT SUFFERING FROM HUMAN IMMUNODEFICIENCY VIRUS INFECTION A TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVE JANSSEN PHARMACEUTICA N.V. (BE) 2000-11-21 US claimed
WO-1999050256-A1 TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS JANSSEN PHARMACEUTICA N.V. (BE) 1999-10-07 WO claimed
US-5344834-A Functionalized vinyl azoles and methods of use SCHERING AKTIENGESELLSCHAFT (DE) 1994-09-06 US claimed
EP-0380712-A1 Process for the preparation of 2,6-dichlorodiphenylaminoacetic-acid derivatives HEUMANN PHARMA GMBH &amp; CO (DE) 1990-08-08 EP claimed
EP-0011928-B1 3,5-DIHYDROXYPENTANOIC ESTER DERIVATIVES HAVING ANTIHYPERLIPAEMIC ACTIVITY, THEIR MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SANKYO COMPANY LIMITED (JP) 1982-04-28 EP claimed
US-4255444-A ANTICHOLESTEROL AGENTS SANKYO COMPANY LIMITED (JP) 1981-03-10 US claimed
US-4248889-A INHIBITORS OF CHOLESTEROL BIOSYNTHESIS SANKYO COMPANY LIMITED (JP) 1981-02-03 US claimed
EP-0011928-A1 3,5-Dihydroxypentanoic ester derivatives having antihyperlipaemic activity, their manufacture and pharmaceutical compositions containing them SANKYO COMPANY LIMITED (JP) 1980-06-11 EP claimed
EP-0010951-A1 4-Hydroxy-2-pyrone derivatives, process for their preparation and their pharmaceutical preparations SANKYO COMPANY LIMITED (JP) 1980-05-14 EP claimed
EP-0003663-A2 Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1979-08-22 EP claimed